Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The acetylcholine (ACh) release machinery at neuromuscular junctions (NMJs) refers to the complex molecular and cellular system responsible for the synthesis, storage, regulated exocytosis, and recycling of ACh from motor neuron terminals to initiate muscle contraction. This machinery is essential for voluntary movement in vertebrates. Key components include choline acetyltransferase (ChAT), synaptic vesicles, voltage-gated Ca(2+) channels, SNARE proteins, nicotinic acetylcholine receptors (nAChRs), and acetylcholinesterase (AChE). Disruption of this machinery leads to neuromuscular disorders like myasthenia gravis and botulism.
N/A
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Release Machinery at Neuromuscular Junctions (N/A).